Iatrogenic hemodilution: a possible cause for avoidable blood transfusions?

A restrictive approach to blood transfusions is recommended by most current guidelines [1, 2]. Others suggest that in some patients a more liberal transfusion strategy may be beneficial [3]. However, the extensive discussions regarding the appropriate transfusion threshold have not adequately addressed the potential impact of iatrogenic hemodilution on the hemoglobin (Hb) level during dynamic clinical…

Read More

Reishi Mushroom of Immortality – Immune support, Anti-diabetic/cancer

REISHI MUSHROOM (Ganoderma ludicum) – “Mushroom of immortality” – Immune support, Antioxidant, Cardiovascular health, Anti-diabetic, Neuroprotective and Anti-Cancer. New Research 2023-2024 Ganoderma lucidum is a medicinal mushroom known in Japan as “Reishi”, which means “spiritual potency”. In China, it is known as “Lingzhi”, which means “divine mushroom”, while in Korea, it is called “Youngzhi”, meaning…

Read More

Comparison of Blood Volume Characteristics In Anemic Patients With Low Versus Preserved Left Ventricular Ejection Fractions

Anemia is a significant co-morbidity in patients with heart failure (HF) irrespective of EF (EF) and is routinely quantified by hemoglobin concentration. Hemodilution as a cause of anemia has been described in systolic HF. This study aims to further investigate the effects of plasma volume in HF patients by 1) assessing prevalence of dilutional anemia…

Read More

City of Hope – The first patient to receive City of Hope’s novel, promising cancer medicine AOH1996 is doing well

LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient to receive its novel, promising cancer medicine AOH1996 is doing well. The Phase 1 clinical trial testing the safety of a potentially cancer-stopping therapeutic developed by City of Hope in…

Read More